As of 2024-12-15, the Relative Valuation of Moberg Pharma AB (publ) (MOB.ST) is (10.80) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 10.28 SEK, the upside of Moberg Pharma AB (publ) based on Relative Valuation is -205.1%.
The range of the Relative Valuation is (9.44) - (11.30) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 30.7x | 23.0x |
| Forward P/E multiples | 19.9x - 23.8x | 22.4x |
| Fair Price | (9.44) - (11.30) | (10.80) |
| Upside | -191.8% - -209.9% | -205.1% |
| Date | P/E |
| 2024-12-10 | -32.57 |
| 2024-12-09 | -32.51 |
| 2024-12-06 | -33.02 |
| 2024-12-05 | -32.51 |
| 2024-12-04 | -33.84 |
| 2024-12-03 | -32.89 |
| 2024-12-02 | -35.18 |
| 2024-11-29 | -37.56 |
| 2024-11-28 | -36.68 |
| 2024-11-27 | -36.61 |
| 2024-11-26 | -38.11 |
| 2024-11-25 | -39.37 |
| 2024-11-22 | -38.42 |
| 2024-11-21 | -40.38 |
| 2024-11-20 | -38.36 |
| 2024-11-19 | -37.46 |
| 2024-11-18 | -36.78 |
| 2024-11-15 | -34.38 |
| 2024-11-14 | -32.09 |
| 2024-11-13 | -32.74 |
| 2024-11-12 | -33.46 |
| 2024-11-11 | -31.58 |
| 2024-11-08 | -34.93 |
| 2024-11-07 | -32.83 |
| 2024-11-06 | -29.99 |
| 2024-11-05 | -27.04 |
| 2024-11-04 | -25.36 |
| 2024-11-01 | -25.08 |
| 2024-10-31 | -26.66 |
| 2024-10-30 | -26.74 |
| 2024-10-29 | -26.09 |
| 2024-10-28 | -25.27 |
| 2024-10-25 | -24.62 |
| 2024-10-24 | -23.50 |
| 2024-10-23 | -22.98 |
| 2024-10-22 | -22.54 |
| 2024-10-21 | -22.47 |
| 2024-10-18 | -24.30 |
| 2024-10-17 | -24.11 |
| 2024-10-16 | -23.88 |
| 2024-10-15 | -25.27 |
| 2024-10-14 | -25.63 |
| 2024-10-11 | -25.40 |
| 2024-10-10 | -24.41 |
| 2024-10-09 | -23.67 |
| 2024-10-08 | -21.97 |
| 2024-10-07 | -22.26 |
| 2024-10-04 | -21.36 |
| 2024-10-03 | -20.64 |
| 2024-10-02 | -20.46 |